Creative Stock Analysis

The current indifference towards the small price fluctuations of Creative Medical Tec could raise concerns from investors as the firm it trading at a share price of 0.0 on very low momentum in volume. The company management teams did not add any value to Creative Medical investors in December. However, most investors can still diversify their portfolios with Creative Medical Tec to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to investors with longer-term investment horizons.
Check out Trending Equities.

Creative Stock Analysis 

The Creative Medical stock analysis report makes it easy to digest most publicly released information about Creative Medical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Creative Stock analysis module also helps to analyze the Creative Medical price relationship with some important fundamental indicators such as market cap and management efficiency.

Creative Stock Analysis Notes

The company recorded a loss per share of 7.68. Creative Medical Tec had not issued any dividends in recent years. The entity had 500.00 - 1.00 split on the 10th of November 2021. Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona. Creative Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. For more info on Creative Medical Technology please contact Timothy Warbington at 833 336 7636 or go to

Creative Medical Tec Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Creative Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Creative Medical Technology or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Creative Medical Tec is not yet fully synchronised with the market data
Creative Medical Tec has some characteristics of a very speculative penny stock
Creative Medical Tec has high likelihood to experience some financial distress in the next 2 years
The company currently holds 2.76 M in liabilities. Creative Medical Tec has a current ratio of 0.73, indicating that it has a negative working capital and may not be able to pay financial obligations when due.
The entity reported the previous year's revenue of 37.5 K. Net Loss for the year was (15.53 M) with profit before overhead, payroll, taxes, and interest of 113.9 K.
Creative Medical Technology currently holds about 2.38 M in cash with (997.46 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.97.
Creative Medical Tec has a frail financial position based on the latest SEC disclosures

Creative Medical SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Creative Medical prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Creative Medical investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Creative Medical Tec specific information freely available to individual and institutional investors to make a timely investment decision.
17th of December 2021
Unclassified Corporate Event
10th of December 2021
Unclassified Corporate Event
8th of December 2021
Unclassified Corporate Event
7th of December 2021
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Entry into a Material Definitive Agreement
9th of November 2021
Financial Statements and Exhibits. Other Events. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year. Material Modifications to Rights of Security Holders
5th of November 2021
Financial Statements and Exhibits. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year. Material Modifications to Rights of Security Holders
22nd of September 2021
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
12th of August 2021
Financial Statements and Exhibits. Unregistered Sales of Equity Securities. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Entry into a Material Definitive Agreement

Creative Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Creative Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Creative Medical Technology backward and forwards among themselves. Creative Medical's institutional investor refers to the entity that pools money to purchase Creative Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Ifp Advisors IncCommon Shares75.01000
North Star Asset Management IncCommon Shares25 K0.0
North Star Asset Management IncCommon Shares25 K1000
North Star Asset Management IncCommon Shares100 K0.0
North Star Asset Management IncCommon Shares100 K0.0
North Star Asset Management IncCommon Shares100 K1000
North Star Asset Management IncCommon Shares64 K1000
Note, although Creative Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Creative Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 14.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Creative Medical's market, we take the total number of its shares issued and multiply it by Creative Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Creative Profitablity

Creative Medical's profitability indicators refer to fundamental financial ratios that showcase Creative Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Creative Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Creative Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Creative Medical's profitability requires more research than a typical breakdown of Creative Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(63.63) (65.31) 
Return on Average Equity 3.34  3.61 
Return on Invested Capital 2.62  2.20 
Return on Sales(245.35) (264.72) 

Management Efficiency

The entity has return on total asset (ROA) of (69.45) % which means that it has lost $69.45 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (1.6) %, meaning that it created substantial loss on money invested by shareholders. Creative Medical management efficiency ratios could be used to measure how well creative medical tec manages its routine affairs as well as how well it operates its assets and liabilities. Return on Average Equity is likely to rise to 3.61 in 2022, whereas Return on Average Assets are likely to drop (65.31)  in 2022. Creative Medical Total Assets are fairly stable at the moment as compared to the past year. Creative Medical reported Total Assets of 825,441 in 2021. Assets Non Current is likely to rise to about 769 K in 2022, whereas Current Assets are likely to drop slightly above 105.7 K in 2022.
Last ReportedProjected for 2022
Book Value per Share(61.82) (66.70) 
Enterprise Value over EBIT(0.90) (0.97) 
Enterprise Value over EBITDA(0.56) (0.60) 
Price to Book Value(0.46) (0.50) 
Tangible Assets Book Value per Share 0.19  0.19 
Enterprise Value19.5 M21 M
Tangible Asset Value112.7 K105.7 K

Creative Medical Tec Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Creative Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Creative Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Creative Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Creative Medical Technical and Predictive Indicators

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Creative Medical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Options Analysis Now


Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module
Check out Trending Equities. Note that the Creative Medical Tec information on this page should be used as a complementary analysis to other Creative Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Tools for Creative Stock

When running Creative Medical Tec price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Money Managers
Screen money managers from public funds and ETFs managed around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing